CHINA ECG EQUIPMENT MARKET FORECAST 2023-2030

On the other hand, the health burden of cardiovascular diseases across the world is on the rise and disproportionately affects residents in rural regions. In 2017, for example, researchers from the Shanghai Institute of Cardiovascular Disease concluded that the morbidity, as well as mortality of cardiovascular disease in China are increasing at exponential rates, despite the government’s active role in the control and prevention of the same. Aligning with this, the early detection of heart ailments, coupled with consistent monitoring and availing necessary treatment, can potentially decrease the health risks linked to CVDs.

On the other hand, the medical device sector in China is being supplemented by a significant spike in demand for high-tech medical device imports that can effectively detect health concerns. Hospitals, healthcare providers, as well as the Chinese government are also striving toward enhancing care quality in the country, thus augmenting the demand for ECG equipment over the upcoming years. As a result, the above-mentioned factors are anticipated to boost market growth in China during the forecast period. 

The China ECG equipment market is segmented into lead type, product, system, and end-user. The end-user segment includes hospitals & clinics, home/ambulatory care, and other end-users. In hospitals & clinics, ECG equipment is utilized for non-acute care, acute care, non-treatment, and other purposes. The high adoption of these devices is accredited to their routine usage in terms of recording the heart’s rhythm and electrical activity. In turn, this helps in better ascertaining whether or not the patient is encountering heart problems or has a cardiac condition. 

In addition, local hospitals are equipped with ECG systems, with doctors highly recommending ECG tests before the patient undergoes surgery. These examinations are also recommended in hospitals & clinics, primarily for patients at risk of heart disease owing to their family history. 

Some of the major companies operating in the China ECG equipment market include Contec Medical Systems Co Ltd, Lepu Medical Technology, Guangdong Biolight Meditech Co Ltd, etc.

Mindray Medical International Limited, headquartered in China, is engaged in the development, marketing, and manufacture of medical devices. These include patient monitoring & life support systems, medical imaging systems, and in-vitro diagnostics products. The company classifies its business into four product lines, namely, Patient Monitoring and Life Support, Medical Imaging Systems, In-Vitro Diagnostics, and Veterinary. 

The company’s BeneHeart R12 is a 12-channel ECG that delivers diagnoses rapidly and accurately, in order to help users meet various clinical demands. The product’s features include user-friendly workflow buttons, an 8-inch high-resolution color display, modern soft-touch hotkeys, an optional touchscreen, and others.